Linear IgA bullous dermatosis induced by atezolizumab: a case report
Linear IgA Bullous Dermatosis (LABD) is a rare immune-mediated vesiculobullous disease that was reported to be induced by infections or medications. Atezolizumab is a monoclonal antibody targeting programmed cell death ligand-1 (PD-L1), it has been used to treat multiple cancers. Here, we report a c...
Saved in:
Main Authors: | Seba Almutairi (Author), Dana Alessa (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linear IgA bullous dermatosis
by: L. F. Znamenskaya, et al.
Published: (2019) -
Linear IgA bullous dermatosis: report of an exuberant case
by: Beatriz Cavalcanti de Souza, et al.
Published: (2013) -
Linear IgA and IgG bullous dermatosis
by: Karina de Almeida Pinto Fernandes, et al.
Published: (2016) -
IgA LINEAR BULLOUS DERMATOSIS IN CHILDHOOD.
by: Ivelina Yordanova, et al.
Published: (2015) -
Rituximab for linear IgA bullous dermatosis
by: Rummit Dhillon, et al.
Published: (2022)